The bank's list of highest-conviction stock picks for 2026 spans numerous sectors and features names including Pepsi and GM.

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Note: the trade details cited in this article come from The Claude Portfolio account on X, a third-party account not ...

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 by 9 percentage ...

SMC Global Ashok Leyland is trading within a symmetrical triangle on the daily chart and appears to be on the verge of a ...

The biotech sector has always held a special appeal for risk-tolerant investors. While these companies face high overhead in the form of towering R&D costs and long lead times for bringing new ...

For most of 2026, the market's story has mostly been on semiconductors and artificial intelligence. Jim Cramer just told investors to look somewhere else. On his CNBC show, the "Mad Money" host called ...

The biotech sector is poised for robust long-term growth, driven by significant developments in drug approvals, innovative therapies, and government-backed initiatives. Hence, investors might consider ...